pd 128907 has been researched along with butaclamol in 1 studies
Studies (pd 128907) | Trials (pd 128907) | Recent Studies (post-2010) (pd 128907) | Studies (butaclamol) | Trials (butaclamol) | Recent Studies (post-2010) (butaclamol) |
---|---|---|---|---|---|
9 | 0 | 4 | 45 | 0 | 16 |
Protein | Taxonomy | pd 128907 (IC50) | butaclamol (IC50) |
---|---|---|---|
D(2) dopamine receptor | Homo sapiens (human) | 0.0023 | |
D | Rattus norvegicus (Norway rat) | 0.0053 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0053 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0053 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0053 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0112 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0034 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akunne, HC; Cooke, LW; Damsma, G; Davis, MD; Georgic, LM; MacKenzie, RG; Pugsley, TA; Shih, YH; Whetzel, SZ; Wikstrom, H | 1 |
1 other study(ies) available for pd 128907 and butaclamol
Article | Year |
---|---|
Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Topics: Animals; Behavior, Animal; Benzopyrans; Brain; CHO Cells; Cricetinae; Dopamine Agonists; Humans; Male; Mice; Mitosis; Oxazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Saimiri; Spiperone | 1995 |